Jetta 12mg Tablet

Jetta 12mg is indicated for the treatment of strongyloidiasis, onchocerciasis, and other susceptible parasitic infestations such as scabies and certain types of lice. The tablet is administered orally, with dosage and duration tailored according to the type and severity of infection, as well as patient weight and clinical response. It is generally well tolerated, though common adverse effects may include dizziness, nausea, diarrhea, and mild skin reactions.

Caution is advised in patients with impaired liver function or those with a history of hypersensitivity to Ivermectin or its components. Jetta 12mg should be used under medical supervision, with adherence to prescribed dosing to ensure efficacy and minimize resistance development. It is contraindicated in children weighing less than 15 kg and during pregnancy unless clearly necessary.

Proper diagnosis and follow-up are essential to monitor therapeutic outcomes and manage any potential side effects.